Rolando Medina will moderate the panel, “Navigating the Regulatory-IP Nexus: Maximizing Exclusivity in an Evolving Policy Landscape” at the Life Sciences Patent Network (LSPN) Spring Conference on Wednesday, April 29, 2026 at 10:05 AM. The panel explore how recent FDA guidance, biosimilar challenges, and regulatory exclusivity mechanisms are reshaping patent prosecution and portfolio management, including: Strategies for securing and maximizing patent term extensions and regulatory exclusivity periods Biosimilar litigation landscape: Defensive strategies and emerging patent challenge trends Leveraging orphan drug designations and pediatric exclusivity for competitive advantage How evolving FDA guidance is impacting patent prosecution strategies and claim drafting Regulatory uncertainty: Adapting your IP strategy to changing agency priorities and standards learn more